Jin Medical International (NASDAQ:ZJYL) Shares Climb 14.6% – What’s Next?

Jin Medical International Ltd. (NASDAQ:ZJYL – Get Free Report) shares rose 14.6% during mid-day trading on Monday. The company traded as high as $3.80 and last traded at $3.8490. Approximately 77,889 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 331,147 shares. The stock had previously closed at $3.36.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Jin Medical International in a research report on Friday, September 25th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock has a consensus rating of “Sell”.

Read Our Latest Stock Report on ZJYL

Jin Medical International Stock Performance

The company has a current ratio of 1.95, a quick ratio of 1.70 and a debt-to-equity ratio of 0.10. The company’s 50-day moving average price is $2.14 and its 200 day moving average price is $2.36.

Jin Medical International Company Profile

(Get Free Report)

Jin Medical International Limited is a medical device company focused on the design, manufacture and sale of mobility and daily-living assistance products. Through its operating subsidiaries in China, the company serves customers seeking equipment intended to support mobility, personal care and home or institutional use.

The company’s product portfolio includes manual wheelchairs, electric wheelchairs, walking aids and other related medical and rehabilitation equipment. Its offerings are marketed through domestic and international sales channels, serving distributors, retailers and other customers in China and overseas markets.

Jin Medical International is incorporated in the Cayman Islands and conducts its primary operating activities in China.

See Also

Receive News & Ratings for Jin Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jin Medical International and related companies with MarketBeat.com's FREE daily email newsletter.